Collaboration Agreements And Business Development Activities - Royalty Pharma Narrative (Details) - USD ($) $ in Millions |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jul. 04, 2025 |
Jun. 28, 2024 |
Jul. 04, 2025 |
Jun. 28, 2024 |
|
| Collaborative Arrangements with Glaxo Smith Kline | ||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||||
| Percent of royalty on net sale | 3.00% | |||
| Collaborative Arrangements with Royalty Pharma | ||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||||
| Royalty expense | $ 21.4 | $ 18.4 | $ 41.7 | $ 35.1 |